𝛼SK or Search

ENTITY

Kyowa Kirin Co Ltd (4151 JP)

93

Analysis

Health Care • Japan

Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.

more

Refresh

Exchange Announcement • 03 Aug 2026 14:30

Appendix To The Consolidated Financial Summary (Ifrs) Fiscal 2026 Semi Annual

Exchange Announcement • 03 Aug 2026 14:30

Consolidated Financial Summary (Ifrs) Fiscal 2026 Semi Annual

Exchange Announcement • 07 May 2026 14:30

Consolidated Financial Summary Fiscal 2026 First Quarter

Exchange Announcement • 07 May 2026 14:30

Appendix To The Consolidated Financial Summary (Ifrs) Fiscal 2026 First Quarter

Exchange Announcement • 30 Mar 2026 15:00

Matters Concerning Controlling Shareholders

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x